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Enzymatic Formation of a Disulfide Bond in Natural Products
PAGE 585
The biochemistry of disulfide bond formation in proteogenic products has been well studied. On the other hand, disulfide
bonds are rarely present in nonribosomally produced natural products, although they can be found in some important anti-
cancer agents. The enzymology of disulfide bond formation in those products is largely unknown. Wang et al. now address
the mechanism of a disulfide bond formation in FK228, an epigenetically acting anticancer natural product made non-
ribosomally by a hybrid nonribosomal peptide synthetase/polyketide synthase pathway in Chromobacterium violaceum
No. 968. Several lines of evidence suggest that DepH, identified in the gene cluster responsible for FK228 production, is
an FAD-dependent pyridine nucleotide disulfide oxidoreductase, specifically and efficiently catalyzing a disulfide bond forma-
tion in FK228.
Bikinin Inhibits Plant GSK3-like Kinases, Brassinosteroids Respond!
PAGE 594
Steroid-derivative brassinosteroids are plant hormones that are involved
in the regulation of plant growth and development. By using a chemical
biology approach, De Rybel et al. identified bikinin, a nonsteroidal synthetic
molecule that induces brassinosteroid responses by specifically inhibiting
seven of the nine GSK3s in plants. The authors demonstrate that inhibition
of GSK3s is the sole activation mode of brassinosteroid signaling and could
indicate new GSK3s as potential regulators of the signaling cascade.
Further insight into the identity of amino acids crucial for GSK3-bikinin inter-
action, reported here, provides a better understanding of GSK3 inhibition
mechanisms and could potentially aid in the development of specific GSK3
inhibitors. (Figure credit: De Rybel et al.)
ClpXP Well-Oiled Translocation Machinery
PAGE 605
The AAA+ ClpXP protease is composed of ClpX, an ATP-dependent chap-
erone organized in a hexameric ring, andClpP, a peptidase organized in a double heptameric ring, contributing 14 active sites.
The protein substrates destined for degradation bind to ATPase, which leads to their unfolding and translocation to the
protease chamber. Barkow et al. use synthetic peptides to investigate polypeptide chain features important for translocation
and demonstrate that ClpXP machinery tolerates a diverse set of substrates with both natural and nonnatural amino acids,
suggesting that ClpX hexamer must be highly adaptable but, at the same time, able to bind the substrate in a manner that
allows coupling between ATP hydrolysis and peptide chain translocation.
b-Lactamase-type Thioesterase Discretion
PAGE 613
Fungal polyketides, most of which are synthesized by iterative type I
polyketide synthases (PKSs), possess structural diversity and a variety
of biological activities. Awakawa et al. now show that a thioesterase
(TE)-less type I PKS, atrochrysone carboxylic acid synthase (ACAS),
in Aspergillus terreus, produces atrochrysone carboxylic acid as a
direct product, in collaboration with a discrete thioesterase, atrochry-
sone carboxyl ACP thioesterase (ACTE). ACTE, showing no similarity
to the general TE domain of nonreducing PKSs, belongs to the
b-lactamase superfamily, which is an exciting finding given that a
b-lactamase-type thioesterase that releases the product from a PKS
in polyketide synthesis has not been previously described.
Albumin and Hsp70: Driving Cytosolic
Anandamide
PAGE 624
The endocannabinoid anandamide is a lipid messenger endowed with a wide variety of biological actions, both centrally and
peripherally. A hot spot in the regulation of anandamide signaling is the identity of the machinery responsible for cellular
uptake and intracellular trafficking of this lipophilic compound. The present study by Oddi et al. provides evidence for the
existence of a constitutive chaperon system, composed of albumin and heat shock protein 70 (Hsp70), that can provide
the rapid and efficient shuttling of anandamide within the cell.
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The trypsin-like serine protease kallikrein-related peptidase 4 (KLK4/prostase) is a potential target for prostate cancer treat-
ment as a consequence of its ability to activate many tumorigenic and metastatic pathways, including the protease activated
receptors (PARs). Here, Swedberg et al. reengineer the naturally occurring sunflower trypsin inhibitor (SFTI) to selectively
block the proteolytic activity of KLK4, thus preparing a small-molecule inhibitor able to selectively block KLK4 and via
KLK4 inactivation of PAR-2 signaling. The applied approach combines molecular modeling and sparse matrix substrate
screening to produce a SFTI variant with high potency and a highly restricted range of inhibitory activity towards KLK4.
Antidepressant with Potent Neurotrophic Activity
PAGE 644
Neurotrophins, the cognate ligands for the Trk receptors, are homodimers
that exert the physiological functions through provoking neurotrophin recep-
tors (TrkA, B, and C) homodimerization. Here, Jang et al. show that a tricyclic
antidepressant drug, amitriptyline, provokes both TrkA and TrkB homo- and
heterodimerization and activation. Amitriptyline acts as an agonist for both
TrkA and TrkB. Strikingly, this small molecule (but not any other antidepres-
sant drug) selectively stimulates endogenous TrkA/TrkB heterodimer forma-
tion in mouse brain. This finding provides a molecular mechanism for dimer-
ization and activation of transmembrane receptor tyrosine kinase (RTK),
establishing a proof-of-concept model for identifying small molecular agonists
and antagonists for RTK.
Inhibitor of the Trio/RhoG/Rac1 Signaling
Pathway
PAGE 657
Exchange factors of the Dbl family (RhoGEFs) are upstream regulators of Rho
GTPases and, as such, they control cell adhesion andmigration pathways. Bouquier et al. identify a small molecule they name
Inhibitor of Trio eXchange 3 (ITX3) as a nontoxic inhibitor of the N-terminal RhoGEF domain of the Trio protein, a key mediator
in nerve and muscle cell differentiation. ITX3 specifically inhibited the cellular effects mediated by endogenous Trio activity in
various cell types, while having no effect on the activity of other GEFs of the Dbl family. The study validates the Dbl family as
druggable targets and opens new possibilities for the development of anti-invasive inhibitors.
Fatty Acid Synthesis Initiation
PAGE 667
Metazoans synthesize palmitate in the cytosol using an ensemble of covalently
linked enzymes but synthesize octanoyl moieties, the lipoyl precursor, in mitochon-
dria using a suite of freestanding enzymes. The acyltransferases responsible for
initiation of fatty acid biosynthesis in the two compartments are distinguished by
their different substrate specificities: the cytosolic enzyme transfers both the acetyl
primer and the malonyl chain extender, whereas the mitochondrial counterpart is
responsible for translocation of only the malonyl substrate. Bunkoczi et al. combine
X-ray crystallography with in silico substrate docking and mutagenesis experiments
to reveal that although the two enzymes adopt a similar fold, subtle differences at
their catalytic centers account for their different specificities.
Chimera for Hybrid Glycopeptides Production
PAGE 676
A promising approach to new drug leads is to engineer the biosynthesis of natural
products to produce novel compounds. Truman et al. report the successful
construction of highly active chimeric glycopeptide glycosyltransferases (GTs). Glycopeptides are clinically indispensable
antibiotics active towards multi-drug-resistant bacteria, and the sugars that decorate them are important determinants of
bioactivity. The authors show that the sugar donor specificity of glycosyltransferases can be controlled by fully swapping
substrate binding domains. Since the vast majority of glycosyltransferases involved in natural product biosynthesis belong
to the same structural superfamily, this may be a general strategy for directing the biosynthesis of clinically important natural
products.
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